No abstract

No abstract

No abstract

Nellix application procedure. Twenty-five patients were judged to be palliative cases after comprehensive discussion at the multidisciplinary team meeting. Of the patients turned down for further intervention, eight (32%) are dead. After Nellixin-Nellix extension, two were successfully treated, one died of bowel infarction, and one required limb extensions for bilateral type IB endoleak. Proximal embolization was successful in 16.7%.Conclusions: This study demonstrates the high midterm failure rates of Nellix EVAS. EVAS explantation is an acceptable technique with favorable outcomes compared with reported endovascular aneurysm repair explantation data. Management with open explantation or Nellix-in-Nellix application should be considered early and offered to those with device failure.

No abstract